Skip to main content
Clinical Trials/CTRI/2021/05/033545
CTRI/2021/05/033545
Completed
未知

To assess the impact of COVID-19 pandemic on depression among pregnant women-A cross-sectional study

JSS college of Pharmacy Ooty0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
JSS college of Pharmacy Ooty
Enrollment
120
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 21, 2021
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
JSS college of Pharmacy Ooty

Eligibility Criteria

Inclusion Criteria

  • Maternal age of 18 years or greater at the time of consent.
  • Gestational week: 32 to 40 weeks (Third trimester)
  • The ability to provide written informed consent.

Exclusion Criteria

  • Pregnant women with the gestational week under six (Early first trimester)
  • Pregnant women with chronic disease like chronic hypertension, kidney and liver disease, pre\-pregnancy diabetes mellitus
  • Patient with reported depression in the past
  • History of use of anti\-depressants and other drugs which cause depression.
  • History of high\-risk pregnancy including abruption placenta, placenta previa, gestational diabetes, coagulation disorders, thrombocytopenia or history of drug abuse.
  • History of autoimmune diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials